<DOC>
	<DOCNO>NCT00943124</DOCNO>
	<brief_summary>This study evaluate : 1. bioequivalence simvastatin simvastatin acid follow dose simvastatin ( ZOCORâ„¢ ) give together one tablet MK0524A component triple combination tablet MK0524B . 2. bioequivalence laropiprant ER niacin administer triple combination tablet MK0524B double combination tablet MK0524A give together simvastatin .</brief_summary>
	<brief_title>MK0524B Bioequivalence Study ( 0524B-070 )</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Subject good health Subject nonsmoker Subject willing follow study guideline Subject history illness might confound result study make participation study unsafe subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>